medigraphic.com
Anales de Otorrinolaringología Mexicana

2013, Number 1

<< Back Next >>

Otorrinolaringología 2013; 58 (1)

Angiosarcoma of face

del Bosque J, Gil R, Padrón RH, Centeno FM

Language: Spanish
References: 28
Page: 45-48
PDF size: 147.46 Kb.


ABSTRACT

We communicate the case of a male patient with left hemifacial tumor of eight months of evolution, not painful, erythematous, with edema and without significant temperature increase. Biopsy revealed high-grade epithelioid angiosarcoma. Angiosarcoma of the face is an extremely rare tumor.


REFERENCES

  1. Guillot B, Raison-Peyron N, Acevedo M, Meunier L, et al. Angiosarcoma of the scalp and face: failure of an interferon alpha treatment. Eur J Dermatol 2000;10:300-302.

  2. Reed RJ, Palomeque FE, Hairston MA III, Krementz ET. Lymphangiosarcoma of the scalp. Arch Dermatol 1966;94:396-402.

  3. Viqueira F, Castro T, Daniel S. Angiosarcoma de cara y cuero cabelludo. Folia dermatológica cubana 2007;1.

  4. Requena L, Sangueza OP. Cutaneous vascular proliferation. Part III. Malignant neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasm. J Am Acad Dermatol 1998;38:143-175.

  5. Repiso B, Pérez-Gil A, Argueta O, Ríos JJ, et al. Angiosarcoma of the face and scalp. A case report. Actas Dermosifiliogr 1999;90:104-108.

  6. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy. Lymphedema. Cancer 1948;1:64-81.

  7. Sordillo PP, Chapman R, Hadju SI. Lymphangiosarcoma. Cancer 1981;48:1674-1679.

  8. Chen KTK, Bauer V, Flam M. Angiosarcoma in postsurgical lymphedema: an unusual occurence in a man. Am J Dermatopathol 1991;13:488-492.

  9. McBride CM, Reeder JW, Smith JL. Angiosarcoma in the lymphedematous limb. South Med J 1969;62:378-380.

  10. Lanchachipa P, Sánchez L, Matos R, Inti Jamanca W, et al. Angiosarcoma cutáneo de la cara y cuero cabelludo. Dermatología Peruana 2002;12:222-226.

  11. Holden CA, Spittle MF, Wilson-Jones E. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 1987;59:1046-1057.

  12. Suster S, Wong TY. On the discriminatory value of anti- HPCA-1 (CD34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am J Dermatopathol 1994;16:353-363.

  13. de Young BR, Wick MR, Fitzgibbon JF, Sirgi KE, Swanson PE. CD31: an immunospecific marker for endothelial differentiation in human neoplasms. Appl Immunohistochem 1993;1:97-100.

  14. De Young BR, Swanson PE, Argenyi ZB, Ritter JH, et al. CD31 immunoreactivity in mesenchimal neoplasm of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentation. J Cutan Pathol 1995;22:215-222.

  15. Gray M, Rosemberg A, Bhan A, Dickersin G. Cytokeratin expresion by epithelioid vascular neoplasms. Mod Pathol 1989;2:34.

  16. Nagano T, Yamada Y, Ikeda T, Kanki H, et al. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer 2007;110:648-651.

  17. Holloway CL, Turner AR, Dundas GS. Cutaneous angiosarcoma of the scalp: a case report of sustained complete response following liposomal doxorubicin and radiation therapy. Sarcoma 2005;9:29-31.

  18. Lankester KJ, Brown RSD, Spittle MF. Complete resolution of angiosarcoma of the scalp with liposomal daunorubicin and radiotherapy. Clin Oncol 1999;11:208-210.

  19. Benbenisty KM, Lang PG, Maize JC. Extensive angiosarcoma on chronically sun-damaged skin. Am J Clin Dermatol 2004;5:53-55.

  20. Pestoni C, Paredes-Suarez C, Peteiro C, Toribio J. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel. J Eur Acad Dermatol Venereol 2005;19:357-359.

  21. Fata F, O’Reilly E, Ilson D. Paclitaxel in the treatment of patients with anglosarcoma of the scalp or face. Cancer 1999;86:2034-2037.

  22. Wollina U, Füller J, Graefe T, Kaatz M, Lopatta E. Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy. J Cancer Res Clin Oncol 2001;127:396-399.

  23. Zietz C, Rössle M, Haas C, Sendelhofert A, et al. MDM- 2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol 1998;153:1425-1433.

  24. Ohguri T, Imada H, Nomoto S, Yahara K, et al. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. Int J Radiat Oncol Biol Phys 2005;61:1446-1453.

  25. Ranpura V, Hapani S, Chuang J, Wu S. Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a metaanalysis of randomized controlled trials. Acta Oncol 2010;49:287-297.

  26. Mendenhall WM, Mendenhall CM, Werning JW, Reith JD, Mendenhall NP. Cutaneous angiosarcoma. Am J Clin Oncol 2006;29:524-528.

  27. Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer 1996;77:2400-2406.

  28. Eiling S, Lischner S, Busch JO, Rothaupt D, et al. Complete remission of a radioresistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin. Br J Dermatol 2002;147:150-153.




2020     |     www.medigraphic.com